The Policy Advisory Council meeting is a members-only event. SWHR's Policy Advisory Council is comprised of industry, nonprofit, and other health care stakeholders that partner with SWHR to support emerging scientific research and public policy that will improve women’s health.
SWHR’s Policy Advisory Council will meet for its quarterly closed-door meeting. The Policy Advisory Council is a forum for industry, […]
The 57th Meeting of the NIH Advisory Committee on Research on Women's Health (ACRWH) will provide a forum for ACRWH members […]
SWHR convened an interdisciplinary Bone Health Working Group of health care providers, researchers, patient advocates, and policy leaders for a closed, roundtable meeting in April 2022. During the roundtable, the Working Group discussed scientific and policy issues in women’s bone health, including strategies for fracture prevention in at-risk women.
SWHR, in partnership with the Bone Health and Osteoporosis Foundation (BHOF) and the American Society for Bone and Mineral Research (ASBMR), hosted a national webinar and congressional briefing to discuss osteoporosis and its disproportionate impact on women as well as its impact on society.
SWHR convened an interdisciplinary Lupus Working Group to discuss scientific and policy issues related to the impact of lupus on women’s health across the lifespan.
SWHR’s Policy Advisory Council will meet for its quarterly closed-door meeting. The Policy Advisory Council is a forum for industry, […]
The SWHR interdisciplinary Psoriatic Arthritis Working Group discussed the significant health, social, and economic impact of psoriatic arthritis on women’s health across the lifespan.
SWHR, UsAgainstAlzheimer’s, and the National Alliance for Caregiving hosted a national webinar and congressional briefing to discuss Alzheimer’s disease and its disproportionate impact on women, and in particular women of color, as well as its health, social, and economic toll on both patients and caregivers.
SWHR convened an interdisciplinary Autoimmune Policy Working Group to discuss policy needs and opportunities as they relate to women’s autoimmune and immune-mediated diseases and conditions across the lifespan.
